Teens With a Reduced Response to Rewards Are More Susceptible to Depression

Novel research shows that a reduced neural response to receiving rewards in teens predicts the first onset of depression, but not anxiety or suicidality. This is independent of pre-existing depressive or anxiety symptoms, as well as age or sex, which are already strong risk factors for depression. The study 新しいタブ／ウィンドウで開く in Biological Psychiatry: Cognitive Neuroscience and Neuroimaging 新しいタブ／ウィンドウで開く, published by Elsevier, is a step toward using brain science to understand and assess mental health risks.

Mood and anxiety disorders among youth are a growing concern and have long-lasting consequences. Very few studies have identified premorbid neural markers that indicate the risk of the onset of these disorders in a teen's life. This is particularly important given that 50% of children who experience one episode of depression or anxiety will go on to experience a second. Among those who have had two episodes, 80% will go on to have a third or more.

Investigators at the University of Calgary, Alberta, Canada, followed a group of 145 teens (64.8% female) with a family history of depressive or anxiety disorders, which put them at very high risk for developing these disorders themselves. Participating families were part of the Calgary Biopsychosocial Risk for Adolescent Internalizing Disorders (CBRAID) study, a longitudinal research program examining premorbid risk factors for first-lifetime onsets of mood and anxiety disorders in adolescence.

Researchers conducted nine- and 18-month follow-ups to assess whether participants had developed a major depressive disorder, anxiety disorder, or suicidal ideation. They found that a blunted response to reward feedback (also known as reward positivity) while playing a game during an EEG scan in which teens were told they either won or lost predicted the first onset of depression, but not anxiety or suicidality. This may suggest that teens who feel less pleasure or satisfaction when receiving rewards are particularly vulnerable to developing depression for the first time in their life.

First author Gia-Huy L. Hoang, second-year master’s student in neuroscience, University of Calgary, adds, "Evidence shows that kids with depressive or anxiety disorders, which often occur at the same time, generally exhibit a blunted response to rewards. Our research suggests that the brain's response to rewards may be a marker that specifically indicates a risk for depression, rather than for anxiety or suicidality, in teens. Using EEG to measure how the brain responds to rewards is a simple and low-cost method to measure this response."

Editor-in-Chief of Biological Psychiatry: Cognitive Neuroscience and Neuroimaging Cameron S. Carter, MD, University of California Irvine, comments, "Depression, anxiety, and suicidality are strongly linked, and are highly disabling and common problems that typically begin during adolescence. Reward processing is closely linked to depression and anxiety. However, little is known about if a blunted response to rewards precedes these conditions and confers risk for depression, anxiety, or suicidality. Research into specific biomarkers that can identify the risk of first-lifetime onsets of these conditions is highly important to understand and assess mental health risks."

Senior investigator Daniel C. Kopala-Sibley, PhD, Hotchkiss Brain Institute, Alberta Children Hospital Research Institute, The Mathison Centre for Mental Health Research & Education, and Department of Psychiatry, Cumming School of Medicine, University of Calgary, concludes, "Our findings are important as we work towards understanding the brain bases of why teens become depressed for the first time in their lives, which may ultimately further our ability to identify those at risk and intervene with them to prevent the onset of these disorders."

Notes for editors

The article is "The Reward Positivity as a Predictor of First Lifetime Onsets of Depression, Anxiety, and Suicidal Ideation in High-Risk Adolescents," by Gia-Huy L. Hoang, BSc, Kent G. Hecker, PhD, Connor Maxey, BSc, Ford Burles, PhD, Olave E. Krigolson, PhD, and Daniel C. Kopala-Sibley, PhD (https://doi.org/10.1016/j.bpsc.2024.10.017 新しいタブ／ウィンドウで開く). It appears online in advance of volume 10, issue 2 (February 2025) of Biological Psychiatry: Cognitive Neuroscience and Neuroimaging 新しいタブ／ウィンドウで開く, published by Elsevier 新しいタブ／ウィンドウで開く.

The article is openly available at https://www.biologicalpsychiatrycnni.org/article/S2451-9022(24)00334-3/fulltext 新しいタブ／ウィンドウで開く.

Copies of this paper are also available to credentialed journalists upon request; please contact Rhiannon Bugno at [email protected] 新しいタブ／ウィンドウで開く. Journalists wishing to interview the study’s authors should contact Daniel C. Kopala-Sibley, PhD, at [email protected] 新しいタブ／ウィンドウで開く, or Kelly Johnston, Sr. Communications Specialist, Cumming School of Medicine, University of Calgary, at +1 403 617 8691 or [email protected] 新しいタブ／ウィンドウで開く.

The authors’ affiliations and disclosures of financial and conflicts of interest are available in the article.

Cameron S. Carter, MD, is Chair of the Department of Psychiatry & Human Behavior at the University of California, Irvine School of Medicine. His disclosures of financial and conflicts of interest are available here 新しいタブ／ウィンドウで開く.

This research was supported by grants from the Canadian Institutes of Health Research (CIHR), the Brain and Behavior Research Foundation through a Young Investigator Award to Daniel C. Kopala-Sibley, the Hotchkiss Brain Institute, the Mathison Centre for Mental Health Research and Education, and the Alberta Children's Hospital Research Institute.

About Biological Psychiatry: Cognitive Neuroscience and Neuroimaging

Biological Psychiatry: Cognitive Neuroscience and Neuroimaging 新しいタブ／ウィンドウで開く is an official journal of the Society of Biological Psychiatry 新しいタブ／ウィンドウで開く, whose purpose is to promote excellence in scientific research and education in fields that investigate the nature, causes, mechanisms and treatments of disorders of thought, emotion, or behavior. In accord with this mission, this peer-reviewed, rapid-publication, international journal focuses on studies using the tools and constructs of cognitive neuroscience, including the full range of non-invasive neuroimaging and human extra- and intracranial physiological recording methodologies. It publishes both basic and clinical studies, including those that incorporate genetic data, pharmacological challenges, and computational modeling approaches. The 2023 Journal Impact Factor^TM score, from Clarivate, for Biological Psychiatry: Cognitive Neuroscience and Neuroimaging is 5.7. https://www.sobp.org/bpcnni 新しいタブ／ウィンドウで開く

エルゼビアについて エルゼビアは、科学情報と分析を牽引するグローバル企業として、研究者や医療従事者が社会の利益のために科学を進歩させ、医療成果を向上させることを支援しています。我々は信頼できるエビデンスベースのコンテンツと高度なAI対応デジタルテクノロジーに基づくソリューションにより、インサイトと重要な意思決定を促進することでこれを実現しています。

エルゼビアは、140 年以上にわたり研究および医療コミュニティの活動を支援してきました。全世界で 2,500 人以上の技術者を含む 9,500 人の従業員がおり、重要な職務における研究者や、図書館員、アカデミックリーダー、資金提供者、政府機関、R&D 関連企業、医師、看護師、将来の医療従事者や教育者を支援することに従事してきました。2,900 誌以上の科学ジャーナルと代表的な参考文献には、Cell Press、The Lancet、Gray's Anatomy など、各分野の主要なタイトルを含みます。 エルゼビア・ファウンデーション 新しいタブ／ウィンドウで開くと共に、開発途上国および世界中の科学、研究、医療分野におけるインクルージョン＆ダイバーシティ 新しいタブ／ウィンドウで開くを推進するため、支援コミュニティと連携して活動しています。 エルゼビアは、プロフェッショナルおよびビジネス顧客向けの情報に基づく分析および意思決定ツールのグローバルプロバイダーである RELX 新しいタブ／ウィンドウで開くグループの一部です。業務内容やデジタルソリューション、コンテンツ詳細については、 www.elsevier.com/ja-jpをご参照ください。